These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6205112)

  • 21. Platelet neutral mucoprotein and plasma fibrinogen.
    Morelli AC; Pedace E; Ibanez AM; Niemetz M
    Medicina (B Aires); 1972; 32(6):573-87. PubMed ID: 4123216
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of carriers in Glanzmann's thrombasthenia.
    Zonneveld GT; van Leeuwen EF; Sturk A; ten Cate JW
    Thromb Haemost; 1983 Jun; 49(3):182-6. PubMed ID: 6224309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical spectrum of Glanzmann's thrombasthenia.
    Badhe BA; Jayanthi S; Datta T
    Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG; Frojmovic MM; Tang SS; White JG
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glanzmann's thrombasthenia. A review illustrated by a case report].
    Berild D; Hasselbalch H; Bjerrum OJ; Hippe E
    Ugeskr Laeger; 1983 Aug; 145(34):2584-5. PubMed ID: 6612884
    [No Abstract]   [Full Text] [Related]  

  • 26. Congenital disorders of platelet function.
    Rao AK
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):65-86. PubMed ID: 2155905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glanzmann's thrombasthenia: updated.
    Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
    Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural studies on the binding sites of fibrinogen on platelet surface during aggregation.
    Morgenstern E; Reimers HJ; Miyashita C
    Acta Histochem Suppl; 1984; 29():183-9. PubMed ID: 6232644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia.
    Niewiarowski S; Levy-Toledano S; Caen JP
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):457-63. PubMed ID: 7324007
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.
    Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M
    J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet satellitism: experimental studies.
    McGregor DH; Davis JW; Liu PI; Gates E; Poindexter AR
    Lab Invest; 1980 Mar; 42(3):343-55. PubMed ID: 6767139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combining ability of glycoproteins IIb, IIIa and Ca2+ in EDTA-treated nonaggregable platelets.
    Zucker MB; Varon D; Masiello NC; Karpatkin S
    Thromb Haemost; 1983 Dec; 50(4):848-51. PubMed ID: 6320488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation and function of platelets. I. Platelet rich plasma. Comparison between 2 methods: gel filtration and albumin density gradient centrifugation. II. A new method using total blood: metrizamide gradient centrifugation].
    Lévy-Toledano S; Bredoux R; Rendu F; Jeanneau C; Savariau E; Dassin E
    Nouv Rev Fr Hematol (1978); 1976; 16(3):367-80. PubMed ID: 796828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations.
    Phillips DR; Baughan AK
    J Biol Chem; 1983 Sep; 258(17):10240-6. PubMed ID: 6309797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PMA induces platelet activation of specific antigens (CD62/CD63) in GpIIb-IIIa deficient platelets from Glanzmann's thrombasthenia.
    Baudouin-Brignole F; Bayle J; Goguel A; Philip PJ
    Platelets; 1997; 8(6):391-5. PubMed ID: 16793673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel Ser123Pro substitution in the MIDAS domain of integrin 3 associated with variant Glanzmann's thrombasthenia in an Indian patient.
    Nair S; Ghosh K; Shetty S; Mohanty D
    Haematologica; 2004 Dec; 89(12):1529-30. PubMed ID: 15590407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.